The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum
- PMID: 9259934
- DOI: 10.1055/s-2007-994133
The efficacy of prophylactic erythromycin in preventing vertical transmission of Ureaplasma urealyticum
Abstract
To determine if prophylactic erythromycin alters the vertical transmission rate of Ureaplasma urealyticum. Randomized prospective study of 51 singleton pregnancies between 22 and 35 weeks' gestation with preterm premature rupture of membranes or preterm labor. Patients received oral erythromycin for 7 days in addition to routine prophylactic intravenous ampicillin or ampicillin alone. Lower genital colonization with U. urealyticum was 33 of 51 (65%). Vertical transmission of U. urealyticum was 25% (3 of 12) in the erythromycin group and 4 of 17 (24%) for the controls. The average interval from randomization to delivery was 303.5 hr in the erythromycin group and 70.9 hr for controls (p = 0.04). Although not statistically significant, histologic chorioamnionitis in patients colonized with Ureaplasma was lower in the erythromycin group (3 of 12, 25%) compared to the controls (10 of 17, 59%). Prophylactic erythromycin does not decrease vertical transmission of Ureaplasma. It may decrease the incidence of histologic chorioamnionitis and increase the latency period.
Similar articles
-
Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery.J Matern Fetal Med. 1999 Jan-Feb;8(1):12-6. doi: 10.1002/(SICI)1520-6661(199901/02)8:1<12::AID-MFM3>3.0.CO;2-8. J Matern Fetal Med. 1999. PMID: 10052839 Clinical Trial.
-
Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants.Eur J Obstet Gynecol Reprod Biol. 2007 Sep;134(1):44-50. doi: 10.1016/j.ejogrb.2006.09.013. Epub 2006 Nov 13. Eur J Obstet Gynecol Reprod Biol. 2007. PMID: 17095137
-
Antibiotic treatment of intra-amniotic infection with Ureaplasma urealyticum. A case report and literature review.Fetal Diagn Ther. 2007;22(2):90-3. doi: 10.1159/000097103. Epub 2006 Nov 27. Fetal Diagn Ther. 2007. PMID: 17135751 Review.
-
[Administration of intrapartum erythromycin for the interruption of the vertical transmission of Ureaplasma urealyticum and its possible relation to the development of bronchopulmonary dysplasia in neonates with less than 32 weeks gestation. Multicenter study].An Esp Pediatr. 1997 Jun;Spec No 1:73-7. An Esp Pediatr. 1997. PMID: 9382274 Review. Spanish. No abstract available.
-
High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery.Acta Obstet Gynecol Scand. 2000 Nov;79(11):973-8. Acta Obstet Gynecol Scand. 2000. PMID: 11081683
Cited by
-
Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.Drugs. 2001;61(13):1893-9. doi: 10.2165/00003495-200161130-00002. Drugs. 2001. PMID: 11708762 Review.
-
Antibiotics for preterm rupture of membranes.Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD001058. doi: 10.1002/14651858.CD001058.pub3. Cochrane Database Syst Rev. 2013. PMID: 24297389 Free PMC article.
-
Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.Pediatr Infect Dis J. 2013 Apr;32(4):394-8. doi: 10.1097/INF.0b013e3182791ae0. Pediatr Infect Dis J. 2013. PMID: 23114371 Free PMC article.
-
Antibiotics for ureaplasma in the vagina in pregnancy.Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD003767. doi: 10.1002/14651858.CD003767.pub3. Cochrane Database Syst Rev. 2011. PMID: 21901685 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical